Saturday, July 2, 2022

< + > FTC Goes After PBMs, Warns Of Legal Action

Last month, the FTC voted unanimously to examine rising list prices of insulin, but also to probe possible anti-competitive practices by PBMs. Proof of the establishment of anti-competitive practices - such as rebate walls - would likely lead to legal action being taken against PBMs.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > The Role of Technology in Addressing Health Equity, Accessibility, and Digital Literacy Among Diverse Patient Populations

When we talk about improving healthcare, there are many,  many different avenues and aspects to work on. Despite the method, the goal is al...